Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.
- Website
- origamitherapeutics.com
- City
- San Diego
- Country
- United States
- YC batch
- Winter 2022
- Team
- 4 people
- Stage
- Early stage
- AI-native
- No
See it on the San Diego mapSource Spot something wrong?
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in San Diego
VedaBio
CRISPR powered Diagnostics with results in minutes.
CB Therapeutics
Fermentation-derived natural products to solve health problems
MedCrypt
MedCrypt gives medical device vendors cybersecurity features in a few…
Recover
Government-funded online addiction treatment
Persephone Biosciences
We are using the gut microbiome to end cancer.
Cisterna Biologics
High quality mRNA for therapeutic application
Claim this profile
Free and instant: prove you run origamitherapeutics.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Origami Therapeutics, Inc. across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Origami Therapeutics, Inc.'s standing on Labspie, or a simple badge. Both link to this profile and update themselves.
